Brief: Targovax Q2 Operating Loss Narrows To NOK 29.7 Mln
Aug 20 (Reuters) - Targovax ASA TRVX.OL :
* Q2 TOTAL OPERATING REVENUE NOK 272,000 VERSUS NOK 6,000
YEAR AGO
* Q2 OPERATING LOSS NOK 29.7 MILLION VERSUS LOSS NOK 44.6
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr5ZG588
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Circio Holding ASA
See all newsBrief: Circio Holding To Cancel Subsequent Offering
Brief: Circio Holding Completes Private Placement Raising NOK 200 Mln In Gross Proceeds
Brief: Circio, Full Circles Therapeutics Collaborate
Brief: Circio, Avenue Biosciences Announce Research Collaboration
Brief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration